Rivier JE - Search Results

1

Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.

Broadbear JH, Winger G, Rivier JE, Rice KC, Woods JH. Broadbear JH, et al. Among authors: rivier je. Neuropsychopharmacology. 2004 Jun;29(6):1112-21. doi: 10.1038/sj.npp.1300410. Neuropsychopharmacology. 2004. PMID: 14997174

2

Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.

Zhao Y, Valdez GR, Fekete EM, Rivier JE, Vale WW, Rice KC, Weiss F, Zorrilla EP. Zhao Y, et al. Among authors: rivier je. J Pharmacol Exp Ther. 2007 Dec;323(3):846-54. doi: 10.1124/jpet.107.123208. Epub 2007 Sep 12. J Pharmacol Exp Ther. 2007. PMID: 17855476

3

Behavioral effects of central administration of the novel CRF antagonist astressin in rats.

Spina MG, Basso AM, Zorrilla EP, Heyser CJ, Rivier J, Vale W, Merlo-Pich E, Koob GF. Spina MG, et al. Neuropsychopharmacology. 2000 Mar;22(3):230-9. doi: 10.1016/S0893-133X(99)00108-6. Neuropsychopharmacology. 2000. PMID: 10693150

4

Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies.

Young EA, Watson SJ, Kotun J, Haskett RF, Grunhaus L, Murphy-Weinberg V, Vale W, Rivier J, Akil H. Young EA, et al. Arch Gen Psychiatry. 1990 May;47(5):449-57. doi: 10.1001/archpsyc.1990.01810170049008. Arch Gen Psychiatry. 1990. PMID: 2139563

5

Effects of low dose ovine corticotropin-releasing hormone in humans: endocrine relationships and beta-endorphin/beta-lipotropin responses.

Watson SJ, Lopez JF, Young EA, Vale W, Rivier J, Akil H. Watson SJ, et al. J Clin Endocrinol Metab. 1988 Jan;66(1):10-5. doi: 10.1210/jcem-66-1-10. J Clin Endocrinol Metab. 1988. PMID: 2826522

6

Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.

Fekete EM, Inoue K, Zhao Y, Rivier JE, Vale WW, Szücs A, Koob GF, Zorrilla EP. Fekete EM, et al. Among authors: rivier je. Neuropsychopharmacology. 2007 May;32(5):1052-68. doi: 10.1038/sj.npp.1301214. Epub 2006 Oct 4. Neuropsychopharmacology. 2007. PMID: 17019404 Free PMC article.

7

Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat.

Rivier JE, Kirby DA, Lahrichi SL, Corrigan A, Vale WW, Rivier CL. Rivier JE, et al. Among authors: rivier cl. J Med Chem. 1999 Aug 12;42(16):3175-82. doi: 10.1021/jm9902133. J Med Chem. 1999. PMID: 10447963

8

Astressin B, a nonselective corticotropin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing hormone pulse frequency in the ovariectomized rhesus monkey.

Vulliémoz NR, Xiao E, Xia-Zhang L, Rivier J, Ferin M. Vulliémoz NR, et al. Endocrinology. 2008 Mar;149(3):869-74. doi: 10.1210/en.2007-1350. Epub 2007 Dec 6. Endocrinology. 2008. PMID: 18063681 Free PMC article.

9

The effect of 'Astressin', a novel antagonist of corticotropin releasing hormone (CRH), on CRH-induced seizures in the infant rat: comparison with two other antagonists.

Baram TZ, Koutsoukos Y, Schultz L, Rivier J. Baram TZ, et al. Mol Psychiatry. 1996 Jul;1(3):223-6. Mol Psychiatry. 1996. PMID: 9118346 Free PMC article.

10

Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.

Fisher L, Rivier C, Rivier J, Brown M. Fisher L, et al. Endocrinology. 1991 Sep;129(3):1312-6. doi: 10.1210/endo-129-3-1312. Endocrinology. 1991. PMID: 1651845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

724 results

Search Page

Filters